Lorelin Depot樂利宜

Lorelin Depot

leuprorelin

Manufacturer:

Dong Kook Pharm

Distributor:

CNW
Concise Prescribing Info
Contents
Leuprorelin acetate
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Prostatic cancer, premenopausal breast cancer Adult 3.75 mg SC once every 4 wk. Endometriosis Adult 3.75 mg SC once every 4 wk. <50 kg 1.88 mg. Initial dose shall be made on the 1st-5th day after the start of menstrual period. Uterine myoma Adult 1.88 mg SC once every 4 wk. Heavy wt patient or those w/ markedly enlarged uterus 3.75 mg. Initial dose should be made on the 1st-5th day after the start of menstrual period. Central precocious puberty 30 mcg/kg SC once every 4 wk, max: 90 mcg/kg.
Contraindications
Undiagnosed abnormal genital bleeding. Pregnancy & lactation.
Special Precautions
Renal disorder due to spinal cord compression or urethremphraxis. Submucous myoma. Prostate cancer patients w/ vertebral metastasis. Women w/ high risk in metabolic bone disease.
Adverse Reactions
Anaphylactic symptoms. Women Transient aggravation of pelvic pain, dysmenorrhea. Hot flushes, vag dryness, decreased libido, dyspareunia. Depression. Men Transient aggravation of bone pain, ureteral obstruction or spinal cord compression. Hot flushes, impotence, decrease in testes size, nausea, vomiting, edema of lower limbs, general pain. Depression.
MIMS Class
Cancer Hormone Therapy / Trophic Hormones & Related Synthetic Drugs
ATC Classification
L02AE02 - leuprorelin ; Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
Presentation/Packing
Form
Lorelin Depot inj 3.75 mg
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in